Kristen L Stephens, Robert G DeVito, Scott T Hollenbeck, Chris A Campbell, John T Stranix
{"title":"Effect of Enhanced Recovery After Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction.","authors":"Kristen L Stephens, Robert G DeVito, Scott T Hollenbeck, Chris A Campbell, John T Stranix","doi":"10.1055/a-2506-1763","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Enhanced Recovery After Surgery (ERAS) pathways have been widely implemented across many surgical practices, including autologous breast reconstruction. However, the benefits of ERAS in the morbidly obese population have yet to be defined.</p><p><strong>Methods: </strong>A retrospective chart review of patients undergoing deep inferior epigastric artery perforator (DIEP) flap breast reconstruction at our institution from 2017 to 2022 was performed. Length of stay (LOS), ICU utilization, opioid usage, cost, and flap outcomes were analyzed in patients with BMI greater than 35 before and after ERAS implementation.</p><p><strong>Results: </strong>35 morbidly obese patients receiving DIEP flap breast reconstruction were identified before ERAS and 18 after ERAS. There were no differences in unilateral vs bilateral or immediate vs delayed reconstruction. LOS decreased with ERAS (3.43 vs 2.06 days, p< 0.0000001). ICU utilization decreased with ERAS (0.94 vs 0.0 days, p< 0.0001). Daily and total opioid usage decreased with ERAS (41.8 vs 17.9 MME, p< 0.0001; 190.5 vs 54.7 MME, p< 0.0001). Financial metrics improved with ERAS, including decreased total cost ($33,454 vs $25,079, p = 0.0002) and increased cost margin ($4,458 vs -$8,306, p= 0.004). There were no differences in donor or recipient site outcomes including flap loss, DVT/PE, hernia/bulge, delayed wound healing, revisions, and blood loss.</p><p><strong>Conclusion: </strong>ERAS pathways maintain benefits in the morbidly obese population undergoing abdominally based autologous breast reconstruction, including decreased length of stay, ICU utilization, opioid use, and cost while maintaining successful reconstruction outcomes.</p>","PeriodicalId":16949,"journal":{"name":"Journal of reconstructive microsurgery","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of reconstructive microsurgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2506-1763","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Enhanced Recovery After Surgery (ERAS) pathways have been widely implemented across many surgical practices, including autologous breast reconstruction. However, the benefits of ERAS in the morbidly obese population have yet to be defined.
Methods: A retrospective chart review of patients undergoing deep inferior epigastric artery perforator (DIEP) flap breast reconstruction at our institution from 2017 to 2022 was performed. Length of stay (LOS), ICU utilization, opioid usage, cost, and flap outcomes were analyzed in patients with BMI greater than 35 before and after ERAS implementation.
Results: 35 morbidly obese patients receiving DIEP flap breast reconstruction were identified before ERAS and 18 after ERAS. There were no differences in unilateral vs bilateral or immediate vs delayed reconstruction. LOS decreased with ERAS (3.43 vs 2.06 days, p< 0.0000001). ICU utilization decreased with ERAS (0.94 vs 0.0 days, p< 0.0001). Daily and total opioid usage decreased with ERAS (41.8 vs 17.9 MME, p< 0.0001; 190.5 vs 54.7 MME, p< 0.0001). Financial metrics improved with ERAS, including decreased total cost ($33,454 vs $25,079, p = 0.0002) and increased cost margin ($4,458 vs -$8,306, p= 0.004). There were no differences in donor or recipient site outcomes including flap loss, DVT/PE, hernia/bulge, delayed wound healing, revisions, and blood loss.
Conclusion: ERAS pathways maintain benefits in the morbidly obese population undergoing abdominally based autologous breast reconstruction, including decreased length of stay, ICU utilization, opioid use, and cost while maintaining successful reconstruction outcomes.
期刊介绍：
The Journal of Reconstructive Microsurgery is a peer-reviewed, indexed journal that provides an international forum for the publication of articles focusing on reconstructive microsurgery and complex reconstructive surgery. The journal was originally established in 1984 for the microsurgical community to publish and share academic papers.
The Journal of Reconstructive Microsurgery provides the latest in original research spanning basic laboratory, translational, and clinical investigations. Review papers cover current topics in complex reconstruction and microsurgery. In addition, special sections discuss new technologies, innovations, materials, and significant problem cases.
The journal welcomes controversial topics, editorial comments, book reviews, and letters to the Editor, in order to complete the balanced spectrum of information available in the Journal of Reconstructive Microsurgery. All articles undergo stringent peer review by international experts in the specialty.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
